The controlling shareholder of Anhui Genuine New Materials (603429.SH) intends to transfer 10.1051% of the company's shares through an agreement.

Anhui Genuine New Materials (603429.SH) announced that on June 18, 2026, the company's controlling shareholder and actual controller, Xu Shanshui, signed a share transfer agreement with Huang Hua and Bi Weiguo. Xu Shanshui intends to transfer 53 million shares of the company's unrestricted tradable shares, accounting for 10.1051% of the total share capital, to Huang Hua and Bi Weiguo through the agreement. Huang Hua intends to acquire 26.5 million shares, representing 5.0526% of the total share capital, while Bi Weiguo intends to acquire 26.5 million shares, also representing 5.0526% of the total share capital. Prior to this equity change, Huang Hua and Bi Weiguo did not hold any shares of the company. After this equity change, Huang Hua will hold 26.5 million shares, accounting for 5.0526% of the total share capital, and Bi Weiguo will hold 26.5 million shares, also accounting for 5.0526% of the total share capital. After this equity change is completed, Huang Hua and Bi Weiguo will become shareholders holding more than 5% of the company's shares. This equity change will not result in any changes to the company's controlling shareholder or actual controller. The background and purpose of this agreement transfer is that the company intends to acquire more than 50% of the shares of Huiju Pharmaceutical by paying in cash. Through this acquisition, Huiju Pharmaceutical will become a subsidiary of the company. The acquisition of part of Huiju Pharmaceutical's shares and the shares acquired by Huang Hua and Bi Weiguo from the company's controlling shareholder Xu Shanshui constitute the overall transaction arrangement of this acquisition.